EUVIMEDScopri EUVIMED
KohortenstudieOpen access · CC BY-NC 4.0

Women with PCOS have a later menopausal transition and a lower prevalence of menopausal symptoms at age 46: A population‐based birth cohort study

Johanna Lavi iD, Susanna Savukoski, Elisa Hurskainen, Meri-Maija Ollila iD, Laure Morin-Papunen iD, Maarit Niinimäki iD, Terhi T Piltonen iD

Acta Obstetricia et Gynecologica Scandinavica · 2026-05 · 105 (5) · 836-846

DOI: 10.1111/aogs.70198 ↗

At a glance

Kohortenstudie in Acta Obstetricia et Gynecologica Scandinavica, published online on 2026-04-08. Written by Johanna Lavi and 6 co-authors. Institution: Research Unit of Clinical Medicine, Department of Obstetrics and Gynecology, Medical Research Center, Oulu University Hospital, University of Oulu, O…. Major MEDLINE topics: Polycystic Ovary Syndrome, Menopause. Cited 6 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Sigrid Jusélius Foundation (TTP), Research Council of Finland (TTP), Novo Nordisk Foundation (TTP), Oulu University UniOgs.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Introduction

Women with polycystic ovary syndrome (PCOS) have been suggested to experience later menopause, yet population‐based studies are lacking. The present study aimed to assess, in a population‐based birth cohort, whether women with PCOS are more likely to experience late peri−/postmenopause or to have menopausal symptoms in their mid‐40s than women without the syndrome. Material and Methods The present study is a long‐term, population‐based prospective cohort study from the Northern Finland Birth Cohort 1966 (NFBC1966). The PCOS group ( n = 380) was identified based on the Rotterdam criteria (oligomenorrhea, hyperandrogenism, or polycystic ovarian morphology according to anti‐Müllerian hormone levels). Women who did not meet the Rotterdam criteria for PCOS were considered as controls ( n = 1469). Late peri−/postmenopause was defined as at least 60 days of amenorrhea accompanied by elevated follicle‐stimulating hormone levels (>25 IU/L) or the use of menopausal hormone therapy. In women who had undergone hysterectomy or were using progestins, menopausal status was defined as elevated follicle‐stimulating hormone levels (>25 IU/L). Menopausal symptoms were self‐reported via questionnaire during a follow‐up visit at age 46.

Results

Women with PCOS had a significantly lower likelihood of being late peri−/postmenopausal in their mid‐40s compared with controls (PCOS: 3.1% vs. Controls: 18.4%; adjusted odds ratio 0.15, 95% confidence interval 0.07–0.32). To support this result, women with PCOS more often reported having regular menstrual cycles and had a lower risk of menopausal symptoms at age 46, even after adjusting for body mass index, education, and smoking status (adjusted odds ratio 0.68, 95% confidence interval 0.51–0.92). Hot flashes and sleep disturbances were less frequent among women with PCOS, but there were no differences in other menopause‐related symptoms, such as vaginal dryness, affective symptoms, memory disturbances, or sexual dysfunction between the study groups.

Conclusions

From the nonselective population data, it was shown that late peri−/postmenopausal status and symptoms were less frequent in women with PCOS at age 46, supporting the idea of prolonged ovarian function in affected women. This should be considered in patient counseling and future studies of fertility, contraception, and menopausal hormone therapy.

Subjects

MeSH terms (MEDLINE)

Polycystic Ovary SyndromeMenopauseHumansFemaleFinlandMiddle AgedProspective StudiesPrevalenceCohort StudiesFollicle Stimulating HormoneAdultHot Flashes

Author keywords

anti‐Müllerian hormonehot flashesmenopausal symptomsmenopausal transitionmenopauseperimenopausepolycystic ovary syndrome

Substances

Follicle Stimulating Hormone

Authors and institutions

  • Research Unit of Clinical Medicine, Department of Obstetrics and Gynecology, Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.
  • Research Unit of Biomedicine and Internal Medicine, Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.

ORCID profiles: Johanna Lavi, Meri-Maija Ollila, Laure Morin-Papunen, Maarit Niinimäki, Terhi T Piltonen

Funding

  • Sigrid Jusélius Foundation (TTP), Research Council of Finland (TTP)
  • Novo Nordisk Foundation (TTP)
  • Oulu University UniOgs
  • Suomen Lääketieteen Säätiö
  • Roche Diagnostics International Ltd (TTP)
  • Oulun Yliopisto
  • Oulun Yliopistollinen Sairaala
  • Ministry of Health and Social Affairs

Cite

APA

Lavi, J., Savukoski, S., Hurskainen, E., Ollila, M. M., Morin-Papunen, L., Niinimäki, M., & Piltonen, T. T. (2026). Women with PCOS have a later menopausal transition and a lower prevalence of menopausal symptoms at age 46: A population‐based birth cohort study. Acta Obstetricia et Gynecologica Scandinavica, 105(5), 836-846. https://doi.org/10.1111/aogs.70198

Vancouver

Lavi J, Savukoski S, Hurskainen E, Ollila MM, Morin-Papunen L, Niinimäki M, et al. Women with PCOS have a later menopausal transition and a lower prevalence of menopausal symptoms at age 46: A population‐based birth cohort study. Acta Obstetricia et Gynecologica Scandinavica. 2026;105(5):836-846. doi:10.1111/aogs.70198

BibTeX
@article{Lavi2026,
  author = {Lavi, Johanna and Savukoski, Susanna and Hurskainen, Elisa and Ollila, Meri-Maija and Morin-Papunen, Laure and Niinimäki, Maarit and Piltonen, Terhi T},
  title = {Women with PCOS have a later menopausal transition and a lower prevalence of menopausal symptoms at age 46: A population‐based birth cohort study},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2026},
  volume = {105},
  number = {5},
  pages = {836--846},
  doi = {10.1111/aogs.70198}
}
Start for free →